Lonza Forms Alliance and Acquires Stake in U.S. Drug Discovery Tech Firm

2:59 AM MST | March 9, 2010 |

Deepti Ramesh

Lonza says it has signed an agreement with drug discovery technology company Odyssey Thera (San Ramon, CA) to make Odyssey Thera’s proprietary protein-fragment complementation assay (PCA) technology, and Odyssey Thera has granted to Lonza an option to...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

Searchable online archive access of the last 2 years of Chemical Week.
Print or digital magazine subscription
Price and market change alerts
Economic data and statistics
Buyers' Guides
Webcasts | whitepapers

search

in this issue

premium

events

free features

advertising

customer care

Lonza Forms Alliance and Acquires Stake in U.S. Drug Discovery Tech Firm

Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

Connect with IHS Chemical Week

Quick links

Our related sites

search

in this issue

premium

events

free features

advertising

customer care

Lonza Forms Alliance and Acquires Stake in U.S. Drug Discovery Tech Firm

Forgot your user ID or password? Click here to have it sent to you.

Not an IHS Chemical Week 24/7 member yet?

Here's why you should be:

Connect with IHS Chemical Week

Quick links

Our related sites

Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week
24/7 member yet?